Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia
Séverine Cathelin, David Sharon, Amit Subedi, Dan Cojocari, Darren C. Phillips, Joel D. Leverson, Kyle J. MacBeth, Brandon Nicolay, Rohini Narayanaswamy, Sébastien Ronseaux, Guowen Liu, Steven M. Chan
Topics & Concepts
VenetoclaxMyeloid leukemiaCancer researchMyeloidBiologyMedicineLeukemiaImmunologyChronic lymphocytic leukemiaAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment